EMA and ECDC collaborate on vaccine safety and effectiveness monitoring studies 30 Dec 2022
The European Medicines Agency (EMA) and European Centre for Disease Prevention and Control (ECDC) held the first meeting of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB) of the Vaccine Monitoring Platform (VMP) in early December.
The VMP is a joint initiative aimed at strengthening the continuous monitoring of the safety and effectiveness of vaccines in the European Union (EU).
Via the VMP they will coordinate and oversee EU-funded, independent post-authorisation studies on vaccines use, safety and effectiveness in EU countries.
Read more.